Anirban Maitra, Scientific Director of Sheikh Ahmed Center for Pancreatic Cancer Research and Professor of Pathology and Translational Molecular Pathology at The University of Texas MD Anderson Cancer Center, shared a post on X:
“Great news for patients with Pancreatic Cancer and other KRAS mutant tumors, and their medical oncologists!
FDA Awards First-Ever National Priority Vouchers to Nine Sponsors.
Wonderful to see RMC-6236 (Daraxonrasib) on that list.”
More posts featuring Anirban Maitra.